| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | See Remarks
1 company
Goldshleger Ilya is a Chief Operating Officer at RXST. Recent filings cover 2 purchases and 60 sales. Those positions are worth an estimated $567K at current prices.
Our model assigns Goldshleger Ilya a strong insider score of 81/100, based on 36 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +65.2%.
Goldshleger Ilya's largest disclosed position is in RXST as Chief Operating Officer, worth about $567K. The recent filings there lean toward selling, a net 166,530 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | RXST Rxsight, Inc. | Chief Operating Officer | Sale+OE | 2,041 | $6.96 | $14,205.36 | -2.4% | - | - | |
| Nov 29, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 3,105 | $46.08 | $143,078.40 | -6.8% | -39.8% | -75.6% | |
| Nov 26, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 6,200 | $45.44 | $281,728.00 | -12.8% | -36.4% | -75.0% | |
| Nov 18, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 7,975 | $45.61 | $363,752.31 | -15.9% | -31.0% | -78.5% | |
| Nov 12, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 1,330 | $46.13 | $61,356.23 | -3.1% | -29.5% | -78.0% | |
| Nov 7, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 3,100 | $55.00 | $170,494.64 | -6.8% | -32.6% | -81.6% | |
| Nov 4, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 3,100 | $51.05 | $158,247.08 | -6.8% | -34.2% | -82.4% | |
| Oct 30, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 3,105 | $51.91 | $161,170.92 | -6.8% | -37.8% | -83.2% | |
| Oct 28, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 6,200 | $50.22 | $311,353.77 | -12.8% | -35.3% | -82.5% | |
| Oct 22, 2024 | RXST Rxsight, Inc. | See Remarks | Sale+OE10b5-1 | 3,100 | $49.68 | $154,001.18 | -6.8% | -38.4% | -83.0% |